Leading pharmacy benefit managers are shifting away from lucractive rebates on biologic drugs and toward lower-cost ...

CVS Health Inc (NYSE:CVS) on Tuesday named Brian Newman as executive vice president and chief financial officer designate, ...

Tom Cowhey, who took on the permanent CFO position at CVS early last year, will serve as a strategic advisor to CEO David Joyner.

The Trump administration has paused the Federal Trade Commission's lawsuit against major pharmacy benefit managers after two ...

CVS Health CEO David Joyner earned $17.8 million in total compensation in 2024. The company reported compensation data for its six highest-paid executives in its annual proxy report, published April 4 ...

Employers, including Express Scripts parent company Cigna, seek to manage GLP-1 costs through programs administered by the ...

CVS Health Chief Financial Officer Tom Cowhey will depart the role, in yet another leadership shuffle at the company. | CVS ...

The U.S. Federal Trade Commission’s lawsuit against major pharmacy benefit managers, including UnitedHealth Group’s Optum, ...

In a year marked by macroeconomic uncertainty and renewed trade tensions that have shaken the equity market, CVS Health CVS has emerged as an unexpected outperformer. After a rough 2024, marked by ...

CVS Health is a BUY. Undervalued with growth potential, it outshines competitors despite sector challenges. See more on CVS ...

Co-production deals with adalimumab biosimilar manufacturers and PBMs have increased biosimilar adoption, but this ...